Paper Details

  1. Home
  2. Paper Details

A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy.

Author: HiraikeHaruko, IchinoseTakayuki, NagasakaKazunori, NakagawaIppei, NishidaHaruka, OnoderaTakako, SasamoriYukifumi, TakahashiYuko, TakeharaKohei, TerashimaTsuyoshi, YatsukiKeita

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Relugolix, an oral GnRH antagonist, has shown promise as a treatment for leiomyoma in Japanese women. However, data on its effectiveness against severe adenomyosis is limited.
Paper Details　
Original Abstract of the Article :
Recently, relugolix, an oral gonadotropin-releasing hormone receptor antagonist, has been considered an effective therapy for leiomyoma based on a phase 3 study in Japanese women. Leiomyoma combined with severe adenomyosis occasionally occurs in perimenopausal women; however, little information on t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375059/

データ提供：米国国立医学図書館（NLM）

A New Oasis in the Treatment of Adenomyosis and Leiomyoma

This case study explores the effectiveness of a new medication, relugolix, in treating a common condition called adenomyosis. It's like discovering a hidden oasis in the vast desert of women's health. Adenomyosis is a condition where the lining of the uterus grows into the muscular wall, causing pain and heavy bleeding. This study explores the potential of relugolix, in combination with another medication called kamishoyosan, as a promising treatment option. This research is like finding a new path through the desert, leading to relief and better management of this condition.

Relugolix and Kamishoyosan: A Powerful Combination

The researchers report a successful case of adenomyosis and leiomyoma treated with relugolix and kamishoyosan. This is like finding a hidden spring in the desert, providing a source of healing and relief. This finding suggests that this combination of medications could be a valuable tool for treating these conditions, offering hope for a more comfortable future.

Empowering Women with New Treatment Options

This case study provides a glimpse into the potential of new treatment options for women with adenomyosis and leiomyoma. It's like discovering a new trail through the desert, opening up possibilities for better health and well-being. Further research is needed to confirm these findings and expand our understanding of these promising medications.

Dr.Camel's Conclusion

This research is like a shimmering oasis in the desert of women's health. It highlights the potential of new medications like relugolix and kamishoyosan to provide effective treatment for adenomyosis and leiomyoma. This research is a testament to the ongoing quest for better health outcomes and the importance of exploring new and innovative therapies.

Date :
  1. Date Completed 2021-10-01
  2. Date Revised 2023-11-07
Further Info :

Pubmed ID

34412607

DOI: Digital Object Identifier

PMC8375059

Related Literature

Article Analysis
・Side Effects of relugolix
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.